The Anticoagulant of 3

Multiple Choice

The anticoagulant of 3.2% sodium citrate is preferred over 3.8% because:

A) It does not require an adjusted redraw on patients with high hematocrits
B) The 3.8% sodium citrate tubes are no longer manufactured
C) The 3.2% sodium citrate has more success with minimizing in vitro platelet activation
D) It is more likely to prevent clotting with difficult draws